Covered recipient · General Payments record
WILLIAM MIN CHOY CHEN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$864.94
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $227.83 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $72.13 | 4 |
| Novo Nordisk AS | $66.17 | 4 |
| PFIZER INC. | $43.42 | 2 |
| Acerta Pharma LLC | $31.50 | 2 |
| Lilly USA, LLC | $14.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $21.97 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117525253 | CMS |
| Amgen Inc. | $18.66 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117525255 | CMS |
| Amgen Inc. | $15.37 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117525257 | CMS |
| Amgen Inc. | $16.13 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117525259 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.90 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105850684 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.60 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105568029 | CMS |
| Lilly USA, LLC | $14.61 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135507478 | CMS |
| Novo Nordisk Inc | $16.48 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096934761 | CMS |
| Novo Nordisk Inc | $16.53 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097650787 | CMS |
| Novo Nordisk Inc | $19.02 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096835057 | CMS |
| Novo Nordisk Inc | $14.14 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097433386 | CMS |
| PFIZER INC. | $27.75 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130988542 | CMS |
| PFIZER INC. | $15.67 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132003071 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.